The tariff classification of Lentiviral Vector from China
No revocation or modification of this ruling appears in the Customs Bulletin issues read here (Nov 6, 2024 through Nov 18, 2026), where CBP publishes most such actions. That is not confirmation that the ruling is still in effect. Confirm its status with CBP before relying on it (ruling on CBP CROSS).
Key passages, quoted from the ruling
- The applicable subheading for the Lentiviral Vector will be 3002.49.0050, Harmonized Tariff Schedule of the United States (HTSUS), which provides for “Vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products: Other: Other.” The general rate of duty is free.
Ruling text
In your letter dated July 14, 2025, you requested a tariff classification ruling. Lentiviral vector is derived from a HIV-1 lentivirus that has been modified by removal of viral replication genes including deletions that result in a self-inactivating lentiviral vector. The lentiviral vector is produced in a HEK293T cell line and purified from the HEK293T cells using multiple different biomanufacturing techniques and is sterile filtered.
The lentiviral vector is formulated in a salt-based solution and is frozen at -80°C for long-term storage and shipment. In your letter, you stated the lentiviral vector will be utilized exclusively for research and development of prototypes for new cancer immunotherapies. Specifically, the lentiviral vector will be used to deliver a specific genetic sequence to cells that have been removed from a patient’s tumor.
The applicable subheading for the Lentiviral Vector will be 3002.49.0050, Harmonized Tariff Schedule of the United States (HTSUS), which provides for “Vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products: Other: Other.” The general rate of duty is free.
Effective March 4, 2025, pursuant to U.S. Note 2(u) to Subchapter III, Chapter 99, all products of China and Hong Kong as provided by heading 9903.01.24, HTSUS, other than products classifiable under headings 9903.01.21, 9903.01.22, and 9903.01.23, HTSUS, will be subject to an additional 20 percent ad valorem rate of duty. At the time of entry, you must report the applicable Chapter 99 heading, i.e. 9903.01.24, in addition to subheading 3002.49.0050, HTSUS, listed above.
Effective April 5, 2025, Executive Orders implemented “Reciprocal Tariffs.” All imported merchandise must be reported with either the Chapter 99 provision under which the reciprocal tariff applies or one of the Chapter 99 provisions covering exceptions to the reciprocal tariffs. At this time, products of China, Hong Kong, and Macau will be subject to an additional ad valorem rate of duty of 10 percent. Your product falls within an excepted subheading.
At the time of entry, you must report the Chapter 99 heading applicable to your product classification, i.e. 9903.01.32, in addition to subheading 3002.49.0050, HTSUS, listed above. The tariffs and additional duties cited above are current as of this ruling’s issuance. Duty rates are provided for your convenience and are subject to change. The text of the most recent HTSUS and the accompanying duty rates are provided at https://hts.usitc.gov/.
This merchandise may be subject to the Federal Food, Drug, and Cosmetic Act and/or The Public Health Security and Bioterrorism Preparedness and Response Act of 2002 (The Bioterrorism Act), which are administered by the U.S. Food and Drug Administration (FDA). Information on the Federal Food, Drug, and Cosmetic Act, as well as The Bioterrorism Act, can be obtained by calling the FDA at 1-888-463-6332, or by visiting their website at www.fda.gov.
The holding set forth above applies only to the specific factual situation and merchandise description as identified in the ruling request.
The text above is an excerpt. The official ruling, with its letterhead, signature and any attachments, is on CBP CROSS (N351298).